ReviewCurrent medicinal chemistry2012
Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors.
Polamarasetty Aparoy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
53 papers cite it
this papercites it